Is APOE useful for menopause?

Whether APOE genotyping is useful for menopause is not supported by strong evidence. APOE (apolipoprotein E) is primarily studied for Alzheimer's disease and cardiovascular risk. Some observational studies have explored links between APOE ε4 and earlier menopause or worsened lipid profiles after menopause, but findings are inconsistent and often underpowered. Menopause is driven by estrogen decline, and while APOE influences lipid metabolism and inflammation, no clinical guidelines recommend APOE testing for menopause management. Consumer DNA tests (e.g., MyBody-X) may include APOE in longevity panels, but they typically note limited utility for menopause. The evidence level is 'unclear' due to heterogeneous study designs and lack of replication. In practice, APOE testing is more relevant for Alzheimer's risk assessment or personalized lipid management, not for predicting menopause onset or symptoms. Safety note: carriers of APOE ε4 should not overinterpret results; medical consultation is essential before any lifestyle or therapeutic changes.